Literature DB >> 10523396

State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action.

A Faggiotto1, R Paoletti.   

Abstract

In addition to their primary mode of action, statins and blockers of the renin-angiotensin system possess common additional properties that are under active investigation. The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of shared effects that target the arterial wall. These and other properties may eventually become exploited for the improved treatment of cardiovascular diseases and of other diseases apparently unrelated to the cardiovascular field, including inflammation and cancer. This review analyzes the current knowledge on the pleiotropic properties of these classes of drugs. Direct comparison indicates that study of the associations among these drugs may eventually disclose additive or synergistic effects that, perhaps even at lower dosages, may provide improved vascular protection and a strong alliance against several atherogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523396     DOI: 10.1161/01.hyp.34.4.987

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

Review 1.  Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.

Authors:  M H Davidson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Vascular pleiotropy of statins: clinical evidence and biochemical mechanisms.

Authors:  A S Callahan
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

Review 3.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

4.  Statin use and risk of prostate cancer: results from a population-based epidemiologic study.

Authors:  Ilir Agalliu; Claudia A Salinas; Philip D Hansten; Elaine A Ostrander; Janet L Stanford
Journal:  Am J Epidemiol       Date:  2008-06-12       Impact factor: 4.897

Review 5.  Limb salvage in women.

Authors:  Tam T T Huynh; Lori Choi
Journal:  Methodist Debakey Cardiovasc J       Date:  2013-04

Review 6.  Angiotensin, inflammation, hypertension, and cardiovascular disease.

Authors:  F C Luft
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

7.  Drug treatment of peripheral arterial disease in the elderly.

Authors:  Wilbert S Aronow
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 8.  Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease.

Authors:  Timo Strandberg; Kaisu Pitkala; Reijo Tilvis
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial.

Authors:  Kevin D Ballard; Richard S Bruno; Richard L Seip; Erin E Quann; Brittanie M Volk; Daniel J Freidenreich; Diana M Kawiecki; Brian R Kupchak; Min-Yu Chung; William J Kraemer; Jeff S Volek
Journal:  Nutr J       Date:  2009-07-22       Impact factor: 3.271

10.  Atherosclerosis, cholesterol, nutrition, and statins--a critical review.

Authors:  Jan-Olaf Gebbers
Journal:  Ger Med Sci       Date:  2007-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.